SI3063278T1 - Izdelava virusnega vektorja - Google Patents

Izdelava virusnega vektorja

Info

Publication number
SI3063278T1
SI3063278T1 SI201430731T SI201430731T SI3063278T1 SI 3063278 T1 SI3063278 T1 SI 3063278T1 SI 201430731 T SI201430731 T SI 201430731T SI 201430731 T SI201430731 T SI 201430731T SI 3063278 T1 SI3063278 T1 SI 3063278T1
Authority
SI
Slovenia
Prior art keywords
creation
viral vector
viral
vector
Prior art date
Application number
SI201430731T
Other languages
English (en)
Slovenian (sl)
Inventor
Paul Michael Howley
Liang Liu
Original Assignee
Sementis Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013904242A external-priority patent/AU2013904242A0/en
Application filed by Sementis Limited filed Critical Sementis Limited
Publication of SI3063278T1 publication Critical patent/SI3063278T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151Methods of production or purification of viral material
    • C12N2710/24152Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SI201430731T 2013-11-01 2014-11-03 Izdelava virusnega vektorja SI3063278T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2013904242A AU2013904242A0 (en) 2013-11-01 Viral vector manufacture
AU2014900370A AU2014900370A0 (en) 2014-02-07 Orthopox vectors and propagation
PCT/AU2014/050330 WO2015061858A1 (en) 2013-11-01 2014-11-03 Viral vector manufacture
EP14858802.3A EP3063278B1 (en) 2013-11-01 2014-11-03 Viral vector manufacture

Publications (1)

Publication Number Publication Date
SI3063278T1 true SI3063278T1 (sl) 2019-04-30

Family

ID=53003022

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201430731T SI3063278T1 (sl) 2013-11-01 2014-11-03 Izdelava virusnega vektorja

Country Status (25)

Country Link
US (2) US10544397B2 (https=)
EP (2) EP3375882B1 (https=)
JP (2) JP6682443B2 (https=)
KR (1) KR102047030B1 (https=)
CN (1) CN106255758B (https=)
AU (1) AU2014344738B2 (https=)
CA (1) CA2931518C (https=)
CY (1) CY1121414T1 (https=)
DK (2) DK3063278T3 (https=)
ES (1) ES2670034T3 (https=)
HR (1) HRP20180789T1 (https=)
HU (1) HUE037718T2 (https=)
IL (1) IL245363B (https=)
LT (1) LT3063278T (https=)
NO (1) NO3063278T3 (https=)
NZ (1) NZ720241A (https=)
PL (1) PL3063278T3 (https=)
PT (1) PT3063278T (https=)
RS (1) RS57290B1 (https=)
RU (1) RU2658487C2 (https=)
SG (1) SG11201603919XA (https=)
SI (1) SI3063278T1 (https=)
SM (1) SMT201800267T1 (https=)
TR (1) TR201807128T4 (https=)
WO (1) WO2015061858A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL264893B (en) * 2016-08-19 2022-08-01 Sementis Ltd Vaccines for viruses
JP2018081568A (ja) * 2016-11-17 2018-05-24 グローリー株式会社 紙幣収納装置および紙幣処理機
IL295154A (en) * 2020-01-28 2022-09-01 Lonza Walkersville Inc Methods for determining viral titer
EP4547689A1 (en) * 2022-06-30 2025-05-07 Bavarian Nordic A/S Mammalian cell line for the production of modified vaccinia virus ankara (mva)
WO2024064608A2 (en) * 2022-09-20 2024-03-28 Intergalactic Therapeutics, Inc. Best1 vectors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604183B1 (fr) 1986-09-23 1988-12-30 Transgene Sa Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho
ATE298370T1 (de) 1994-04-29 2005-07-15 Baxter Healthcare Sa Rekombinante poxviren mit fremdenpolynukleotiden in wichtigen regionen
WO2004015118A1 (en) * 2002-08-07 2004-02-19 Bavarian Nordic A/S Vaccinia virus host range genes to increase the titer of avipoxviruses
FR2884255B1 (fr) * 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
CA2658301A1 (en) * 2006-08-04 2008-02-07 Dublin City University A method of producing recombinant biological products

Also Published As

Publication number Publication date
CN106255758A (zh) 2016-12-21
ES2670034T3 (es) 2018-05-29
WO2015061858A1 (en) 2015-05-07
AU2014344738B2 (en) 2019-03-21
CY1121414T1 (el) 2020-05-29
DK3063278T3 (en) 2018-06-06
EP3063278B1 (en) 2018-02-28
PT3063278T (pt) 2018-05-25
KR102047030B1 (ko) 2019-11-20
RU2016121425A (ru) 2017-12-04
JP6682443B2 (ja) 2020-04-15
US10544397B2 (en) 2020-01-28
IL245363B (en) 2020-01-30
DK3375882T3 (da) 2019-12-16
HUE037718T2 (hu) 2018-09-28
JP2020039340A (ja) 2020-03-19
IL245363A0 (en) 2016-06-30
EP3375882A1 (en) 2018-09-19
SG11201603919XA (en) 2016-07-28
PL3063278T3 (pl) 2018-08-31
AU2014344738A1 (en) 2016-06-09
US20170029784A1 (en) 2017-02-02
SMT201800267T1 (it) 2018-07-17
NO3063278T3 (https=) 2018-07-28
EP3375882B1 (en) 2019-10-16
NZ720241A (en) 2019-10-25
KR20160079868A (ko) 2016-07-06
HRP20180789T1 (hr) 2018-09-07
RU2658487C2 (ru) 2018-06-21
CA2931518C (en) 2021-03-09
EP3063278A4 (en) 2017-04-12
LT3063278T (lt) 2018-07-10
HK1223395A1 (en) 2017-07-28
JP2016534755A (ja) 2016-11-10
US20200190482A1 (en) 2020-06-18
RS57290B1 (sr) 2018-08-31
EP3063278A1 (en) 2016-09-07
CA2931518A1 (en) 2015-05-07
TR201807128T4 (tr) 2018-06-21
CN106255758B (zh) 2020-06-23

Similar Documents

Publication Publication Date Title
UY4298S (es) Carcasa
DK3087183T3 (da) Modulation af angiopoietin-3-lignende ekspression
DK2970954T3 (da) Modifikation af polypeptider
DK2986722T3 (da) Manipulerede phenylalaninammoniak-lyasepolypeptider
HUE042443T2 (hu) GPR6 tetrahidropiridopirazin-modulátorai
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
EP2949543A4 (en) STROLLER
DK2965026T3 (da) Generering af slushice
DK2943561T3 (da) Fotobioreaktor
LT3030259T (lt) Peptidai
DE102013106534B8 (de) Chromatographiepipettenspitze
SI3063278T1 (sl) Izdelava virusnega vektorja
EP2963676A4 (en) susceptor
DK2968528T3 (da) Immunmodulation
DK2958935T3 (da) Vaccine
DE112014001252A5 (de) Aufbissschiene
ES1093531Y (es) Bañera-cambiador bebé flexible
ES1121705Y (es) Perfil en T invertida
TH1501006933A (th) วิธีการปฎิบัติการก๊าซ
UA25427S (uk) Кивок
DK3071509T3 (da) En donkraft
UY4342S (es) Carcasa
BR302013006179S1 (pt) Configuração aplicada em embarcação
BR302013005554S1 (pt) Configuração aplicada em embarcação
DE202013004317U8 (de) Bergehilfe